115 related articles for article (PubMed ID: 25366476)
1. 17-Dimethylaminoethylamino-17-demethoxygeldanamycin attenuates inflammatory responses in experimental stroke.
Qi J; Han X; Liu HT; Chen T; Zhang JL; Yang P; Bo SH; Lu XT; Zhang J
Biol Pharm Bull; 2014; 37(11):1713-8. PubMed ID: 25366476
[TBL] [Abstract][Full Text] [Related]
2. Heat shock protein 90 inhibitors attenuate inflammatory responses in atherosclerosis.
Madrigal-Matute J; López-Franco O; Blanco-Colio LM; Muñoz-García B; Ramos-Mozo P; Ortega L; Egido J; Martín-Ventura JL
Cardiovasc Res; 2010 May; 86(2):330-7. PubMed ID: 20154064
[TBL] [Abstract][Full Text] [Related]
3. Heat shock protein 90 inhibition by 17-Dimethylaminoethylamino-17-demethoxygeldanamycin protects blood-brain barrier integrity in cerebral ischemic stroke.
Qi J; Liu Y; Yang P; Chen T; Liu XZ; Yin Y; Zhang J; Wang F
Am J Transl Res; 2015; 7(10):1826-37. PubMed ID: 26692927
[TBL] [Abstract][Full Text] [Related]
4. Heat shock protein 90 inhibition by 17-DMAG attenuates abdominal aortic aneurysm formation in mice.
Qi J; Yang P; Yi B; Huo Y; Chen M; Zhang J; Sun J
Am J Physiol Heart Circ Physiol; 2015 Apr; 308(8):H841-52. PubMed ID: 25637544
[TBL] [Abstract][Full Text] [Related]
5. The Hsp90 Inhibitor 17-DMAG Attenuates Hyperglycemia-Enhanced Hemorrhagic Transformation in Experimental Stroke.
Zhang J; Wang K; Qi J; Cao X; Wang F
Biomed Res Int; 2021; 2021():6668442. PubMed ID: 33614785
[TBL] [Abstract][Full Text] [Related]
6. Ruscogenin reduces cerebral ischemic injury via NF-κB-mediated inflammatory pathway in the mouse model of experimental stroke.
Guan T; Liu Q; Qian Y; Yang H; Kong J; Kou J; Yu B
Eur J Pharmacol; 2013 Aug; 714(1-3):303-11. PubMed ID: 23911884
[TBL] [Abstract][Full Text] [Related]
7. Targeted cancer therapy through 17-DMAG as an Hsp90 inhibitor: Overview and current state of the art.
Mellatyar H; Talaei S; Pilehvar-Soltanahmadi Y; Barzegar A; Akbarzadeh A; Shahabi A; Barekati-Mowahed M; Zarghami N
Biomed Pharmacother; 2018 Jun; 102():608-617. PubMed ID: 29602128
[TBL] [Abstract][Full Text] [Related]
8. HSP90 inhibition by 17-DMAG reduces inflammation in J774 macrophages through suppression of Akt and nuclear factor-κB pathways.
Shimp SK; Parson CD; Regna NL; Thomas AN; Chafin CB; Reilly CM; Nichole Rylander M
Inflamm Res; 2012 May; 61(5):521-33. PubMed ID: 22327510
[TBL] [Abstract][Full Text] [Related]
9. The apoptotic effect and associated signalling of HSP90 inhibitor 17-DMAG in hepatocellular carcinoma cells.
Leng AM; Liu T; Yang J; Cui JF; Li XH; Zhu YN; Xiong T; Zhang G; Chen Y
Cell Biol Int; 2012 Oct; 36(10):893-9. PubMed ID: 22694478
[TBL] [Abstract][Full Text] [Related]
10. Targeting HSP90 Ameliorates Nephropathy and Atherosclerosis Through Suppression of NF-κB and STAT Signaling Pathways in Diabetic Mice.
Lazaro I; Oguiza A; Recio C; Mallavia B; Madrigal-Matute J; Blanco J; Egido J; Martin-Ventura JL; Gomez-Guerrero C
Diabetes; 2015 Oct; 64(10):3600-13. PubMed ID: 26116697
[TBL] [Abstract][Full Text] [Related]
11. 17-DMAG targets the nuclear factor-kappaB family of proteins to induce apoptosis in chronic lymphocytic leukemia: clinical implications of HSP90 inhibition.
Hertlein E; Wagner AJ; Jones J; Lin TS; Maddocks KJ; Towns WH; Goettl VM; Zhang X; Jarjoura D; Raymond CA; West DA; Croce CM; Byrd JC; Johnson AJ
Blood; 2010 Jul; 116(1):45-53. PubMed ID: 20351313
[TBL] [Abstract][Full Text] [Related]
12. 17-DMAG, an HSP90 Inhibitor, Ameliorates Multiple Organ Dysfunction Syndrome via Induction of HSP70 in Endotoxemic Rats.
Wang YL; Shen HH; Cheng PY; Chu YJ; Hwang HR; Lam KK; Lee YM
PLoS One; 2016; 11(5):e0155583. PubMed ID: 27224288
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of heat shock protein (molecular weight 90 kDa) attenuates proinflammatory cytokines and prevents lipopolysaccharide-induced liver injury in mice.
Ambade A; Catalano D; Lim A; Mandrekar P
Hepatology; 2012 May; 55(5):1585-95. PubMed ID: 22105779
[TBL] [Abstract][Full Text] [Related]
14. HSP90 inhibition by 17-DMAG attenuates oxidative stress in experimental atherosclerosis.
Madrigal-Matute J; Fernandez-Garcia CE; Gomez-Guerrero C; Lopez-Franco O; Muñoz-Garcia B; Egido J; Blanco-Colio LM; Martin-Ventura JL
Cardiovasc Res; 2012 Jul; 95(1):116-23. PubMed ID: 22547655
[TBL] [Abstract][Full Text] [Related]
15. Heat shock protein 90 inhibitor enhances apoptosis by inhibiting the AKT pathway in thermal-stimulated SK-MEL-2 human melanoma cell line.
Shin MK; Jeong KH; Choi H; Ahn HJ; Lee MH
J Dermatol Sci; 2018 Jun; 90(3):357-360. PubMed ID: 29433909
[TBL] [Abstract][Full Text] [Related]
16. Monitoring therapeutic response of human ovarian cancer to 17-DMAG by noninvasive PET imaging with (64)Cu-DOTA-trastuzumab.
Niu G; Li Z; Cao Q; Chen X
Eur J Nucl Med Mol Imaging; 2009 Sep; 36(9):1510-9. PubMed ID: 19440708
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of Hsp90 inhibition for induction of apoptosis and inhibition of growth in cervical carcinoma cells in vitro and in vivo.
Schwock J; Pham NA; Cao MP; Hedley DW
Cancer Chemother Pharmacol; 2008 Apr; 61(4):669-81. PubMed ID: 17579866
[TBL] [Abstract][Full Text] [Related]
18. 17-DMAG induces heat shock protein 90 functional impairment in human bladder cancer cells: knocking down the hallmark traits of malignancy.
Karkoulis PK; Stravopodis DJ; Voutsinas GE
Tumour Biol; 2016 May; 37(5):6861-73. PubMed ID: 26662567
[TBL] [Abstract][Full Text] [Related]
19. The effects of heat shock protein 90 inhibitors on apoptosis and viral replication in primary effusion lymphoma cells.
Higashi C; Saji C; Yamada K; Kagawa H; Ohga R; Taira T; Fujimuro M
Biol Pharm Bull; 2012; 35(5):725-30. PubMed ID: 22687408
[TBL] [Abstract][Full Text] [Related]
20. Heat shock protein 70 and AMP-activated protein kinase contribute to 17-DMAG-dependent protection against heat stroke.
Tsai YC; Lam KK; Peng YJ; Lee YM; Yang CY; Tsai YJ; Yen MH; Cheng PY
J Cell Mol Med; 2016 Oct; 20(10):1889-97. PubMed ID: 27241357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
